$CNC

KOSTER CHRISTOPHER sold $3.8M of CNC

KOSTER CHRISTOPHER (Secretary & General Counsel) sold 56,500 shares of CENTENE CORP (CNC) at $66.90 ($3.78M total) on 2026-08-26.

Original reporting
SEC EDGAR · KOSTER CHRISTOPHER
Published Aug 27, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CNC
Neutral
medium confidence
Mentioned
$CNC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNCNeutralLow
01

Why it matters

The sale reduces insider ownership but is unlikely to move the stock significantly.

02

Market read

Provides fresh insider transaction data for traders monitoring CNC.

03

What to watch

Potential upcoming earnings or strategic moves not disclosed.

Relevance 6/10Novelty 6/10Timing: reported after market close on 2026-08-26

Background

Form 4 filing discloses insider transactions to the SEC.

Company-level read

Ticker impact

$CNCNeutralMedium confidence
Context

Officer Christopher Koster sold 56,500 shares for $3.78M, reducing his stake to 248,854 shares.

Expected impact

Potential short-term pressure on CNC stock.

Evidence & confidence

Officer sale of $3.8M is material but not large enough to trigger major price move.

Market effects

Minimal impact on health insurance sector.

None.

None.

Counterpoint

Insider sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Centene Corp

    US-listed health insurer (ticker CNC).

  • Christopher Koster

    Secretary & General Counsel of Centene.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CNCHigh

ACA fraud crackdown threatens health insurer profits in 2026

Vice President JD Vance announced 760,000 ACA enrollees were dropped due to fraud, with 400,000 under review. Insurers like Centene, Molina, Elevance, and UnitedHealth saw stock declines. Experts warn of squeezed margins in 2026-2027 due to a less healthy risk pool. Premium rates for 2027 are locked, and insurers may push for higher 2028 rates. Brokers, who drive 75% of sign-ups, face new restrictions and potential reputational damage.

$CNCMed

CNC Looks 14.6% Undervalued on GF Value™ as Market Prices in Gro

Centene Corporation (CNC) reaffirmed its 2026 adjusted diluted EPS forecast, expecting it to exceed $4.80, slightly below analyst consensus. The company's P/S ratio is 0.16, below its historical median and industry average, reflecting market skepticism. Its GF Score™ is 72/100, indicating moderate financial health. Insider activity shows no buying and $14.6 million in selling, while institutional sentiment is mixed.

$CNCMed

2 Non-AI Giants to Buy on Solid Guidance and Lucrative Valuation

Centene Corp. (CNC) and Archer-Daniels-Midland Co. (ADM) are highlighted for strong performance and attractive valuations. CNC expects 2026 revenues of $173-$177B and adjusted EPS over $4.80, with a forward P/E of 13.58X. ADM raised 2026 adjusted earnings guidance to $5.15-$5.60 per share, with a forward P/E of 16.60X.

$CNCMed

CNC, OSCR Stocks Rally After Baird Calls Risk Adjustment Results Favorable

Centene (CNC) and Oscar Health (OSCR) shares rose 6% and 12% respectively after Baird reported favorable risk adjustment results. Baird noted the outcomes support Centene's Q4 commentary and align with Oscar's June investor conference remarks. Molina (MOH) shares also rose 2% despite a minor negative impact. The Centers for Medicare & Medicaid Services released final 2025 risk adjustment data on June 30, affecting insurers' earnings.